Neuberger Berman Group
BSX icon

Neuberger Berman Group’s Boston Scientific BSX Stock Holding History

Neuberger Berman Group’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$551K Buy
+12,900
New +$700K ﹤0.01% 1757

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Neuberger Berman Group's BSX Position: Q2 2026 in Review

Neuberger Berman Group reduced its Boston Scientific (BSX) stake by 70% in Q2 2026, selling an estimated $269M and leaving 2,126,406 shares worth $90.8M. The position accounts for 0.06% of the portfolio, ranked #371.

Neuberger Berman Group first reported a position in BSX in Q2 2013 and has held it in 53 quarters since. The position peaked at $534M in Q2 2023. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Neuberger Berman Group held 2,126,406 shares of Boston Scientific worth $90.8M as of Q2 2026.
  • Neuberger Berman Group sold 4,946,488 Boston Scientific shares in Q2 2026, an estimated $269M.
  • Boston Scientific made up 0.06% of Neuberger Berman Group's portfolio in Q2 2026, its #371 holding.
  • Neuberger Berman Group first reported a position in Boston Scientific in Q2 2013 and has held it in 53 quarters since.
  • Neuberger Berman Group's Boston Scientific position peaked at $534M in Q2 2023.
  • 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Neuberger Berman Group's 13F filing for Q2 2026, filed 13 Aug 2026.